Drug
Cdx 1127
Cdx 1127: highest development phase Phase 1, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX-1127 NCT01460134 | Phase 1 | CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma |
Latest
No recent events.
Follow Cdx 1127 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.